Free Trial

Regulus Therapeutics (RGLS) SEC Filings & 10K Form

$2.29
+0.03 (+1.33%)
(As of 05/31/2024 ET)

Recent Regulus Therapeutics SEC Filings

DateFilerForm TypeView
05/21/2024
3:20 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:21 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:21 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:16 PM
Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:33 PM
Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:54 PM
Regulus Therapeutics (Filer)
Form 424B5
04/21/2024
11:15 PM
Regulus Therapeutics (Filer)
Form EFFECT
04/19/2024
3:13 PM
Regulus Therapeutics (Filer)
Form ARS
04/10/2024
9:06 AM
FMR LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
04/09/2024
3:55 PM
Regulus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/25/2024
3:18 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G
03/22/2024
3:03 PM
Deep Track Capital, LP (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G
03/21/2024
3:28 PM
Regulus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
3:18 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
3:30 PM
Regulus Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G
03/18/2024
8:13 PM
Growth Equity Opportunities V, LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13D/A
03/15/2024
3:19 PM
PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
3:57 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:49 AM
FMR LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
02/06/2024
10:06 AM
Regulus Therapeutics (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G/A
01/18/2024
7:22 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:23 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:24 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
9:25 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
01/17/2024
4:16 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
4:18 PM
Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
4:04 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
4:08 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:11 PM
Regulus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/09/2024
11:15 PM
Regulus Therapeutics (Filer)
Form EFFECT
12/27/2023
3:16 PM
Regulus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/14/2023
3:40 PM
Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:31 PM
RASTETTER WILLIAM H (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:34 PM
Regulus Therapeutics (Issuer)
Rosen Hugh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:19 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:21 PM
Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
3:53 PM
Regulus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2023
3:46 PM
BALTIMORE DAVID (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:47 PM
Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:48 PM
Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:49 PM
Nunn Jason Raleigh (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This military-backed stock “owns” AI market (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
06/13/2023
3:50 PM
PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:45 PM
Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2023
3:48 PM
Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RGLS) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners